Remove 2016 Remove Leads Remove Networking
article thumbnail

Klick Health Acquires Peregrine Market Access, Further Cementing its Position as the Leading Go-To Commercialization Partner in Life Sciences

PM360

Acquisition highlights companies shared commitment to clients, workplace culture, and attracting the industrys best people TORONTO, ON/SARATOGA SPRINGS, NY January 7, 2025 Klick Health today announced it has acquired Peregrine Market Access, a leading market access strategy and value communications specialist in life sciences.

article thumbnail

EMA issues guidance amidst European medicine shortage

Pharmaceutical Technology

The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain. Shortages can lead to medicine rationing and delay in critical treatments, with a significant impact on patient care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Targeting ovarian cancer with a novel antibody therapeutic

European Pharmaceutical Review

AbbVie has leading positions in haematology oncology treatments with BTK and BCL-2 inhibitors as foundational therapies in CLL and other blood cancers. She joined AbbVie in 2016, as Head of Medical Affairs, Canada. National Comprehensive Cancer Network. Plymouth Meeting, PA: National Comprehensive Cancer Network 2022.

Medical 98
article thumbnail

HeartBeam Announces Acquisition of LIVMOR Assets

Legacy MEDSearch

Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring. The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing cutting-edge FDA-cleared product.

article thumbnail

NeuroLogica Announces FDA 510(k) Clearance of BodyTom® 64

Legacy MEDSearch

Trauma/ER: The BodyTom 64’s unique combination of internal lead shielding and battery operation allows any standard trauma bay to be transformed into an advanced CT imaging suite. The BodyTom 64 brings the power of innovative imaging to patients’ bedsides safely and efficiently. About NeuroLogica. NeuroLogica Corp.,

FDA 92
article thumbnail

Strategies for Combination Therapy in Oncology: Part One – Business as Usual

PM360

Between May 1, 2016, and May 31, 2021, 42% of all U.S. When 1+1 ≠ 2 In theory, combining two or more branded agents can lead to a price that exceeds SoC monotherapy. Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016–2021.” JAMA Network Open 5 , no. References: 1. Lythgoe, and Vinay Prasad.

article thumbnail

IP maintenance – a hidden priority

Clarivate

Despite the turbulent economic landscape, the number of patents in force grew to over 15m worldwide in 2020, with an average 7% annual growth 2016-2019. An error as small as a mistaken date or additional digit could lead to an incorrect renewal date calculation and potential lapse. Agent network management. Conclusion.